Zobrazeno 11 - 20
of 990
pro vyhledávání: ''
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-17 (2021)
BMC Cancer
BMC Cancer
BackgroundProsthesis-related complications, after knee reconstruction with endoprosthesis during operation for tumors around the knee, remain an unresolved problem which necessitate a revision or even an amputational surgery. The purpose of the curre
Autor:
Tarek Hashem, Chandrasekhar Chikatapu, Bivas Biswas, Yoke Fui Wong, K. Slimane, Ravindran Kanesvaran, Sara Ingles, Mustafa Erman, Chun Sen Lim, Lingwu Chen, Hsiao-Jen Chung, Bulent Karabulut, P. Danchaivijitr
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cancer
BMC Cancer
Background Clinical effectiveness and safety data of pazopanib in patients with advanced or mRCC in real-world setting from Asia Pacific, North Africa, and Middle East countries are lacking. Methods PARACHUTE is a phase IV, prospective, non-intervent
Autor:
Sook-Kyoung Heo, Eui-Kyu Noh, Yoo Jin Lee, Yerang Shin, Youjin Kim, Hyeon-Su Im, Hyeyeong Kim, Su Jin Koh, Young Joo Min, Jae-Cheol Jo, Yunsuk Choi
Publikováno v:
BMC Cancer. 22
BackgroundSevere graft versus host disease (GVHD) is the main reason for non-relapse mortality following allogeneic hematopoietic cell transplantation (HCT). We investigated the serum protein profiles of patients who had undergone HCT to identify pre
Autor:
Yongqiang Zheng, Haotian Ma, Pengcheng Yang, Ying Chen, Yun Yang, Kaixu Yu, Jiayuan Chen, Bian Wu
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Cancer
BMC Cancer
Background Receiving a cancer diagnosis may trigger immediate fatal non-cancer health outcomes in addition to dying of cancer itself. We aim to investigate the full pattern of non-cancer deaths in patients within a year of a cancer diagnosis. Methods
Autor:
Akihisa Kamataki, Naoya Suzuki, Kosuke Katayama, Kenichiro Asano, Akira Kurose, Hiroki Ohkuma, Toshio Fumoto, Seiko Hasegawa, Masashi Matsuzaka, Kenichi Akasaka
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Cancer
BMC Cancer
Background This investigator-initiated, open-label, single-arm, single-institute study was conducted to investigate the effectiveness of induction combination chemoradiotherapy and long-term maintenance therapy with temozolomide (TMZ) plus interferon
Autor:
Nelly Firmin, C. Touraine, Véronique D'Hondt, L. Roca, S Pouderoux, Hélène de Forges, Lobna Rifai, Séverine Guiu, Marie Viala, William Jacot, Gilles Romieu, Manon Metge
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Cancer
BMC Cancer, BioMed Central, 2021, 21 (1), pp.815. ⟨10.1186/s12885-021-08563-4⟩
BMC Cancer
BMC Cancer, BioMed Central, 2021, 21 (1), pp.815. ⟨10.1186/s12885-021-08563-4⟩
Background Changes in calcium metabolism and calcium urinary excretion during chemotherapy have not been thoroughly assessed in patients with early breast cancer (EBC), a population who frequently present vitamin D insufficiency. As hypercalciuria is
Autor:
Semi Harrabi, Meinhard Kieser, Sebastian Adeberg, Kristin Lang, Jürgen Debus, Klaus Herfarth, Thomas Held
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Cancer
BMC Cancer
Background Adenoid cystic carcinoma is a rare form of head and neck cancer with a slow, but aggressive growth pattern which remains a challenge for local tumor control. Based on phase II data, radiation treatment using partially high LET radiation re
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cancer
BMC Cancer
Background There are no epidemiological studies describing rare cancers in Western Australia (WA). We aimed to fill this gap by estimating the incidence and five-year survival of rare, less common and common cancers in WA, based on definitions for ra
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-21 (2021)
BMC Cancer
BMC Cancer
Background Due to its rarity and high heterogeneity, neither established guidelines nor prospective data are currently available for using chemotherapy in the treatment of appendiceal cancer. This study was to determine the use of chemotherapy and it
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-6 (2021)
BMC Cancer
BMC Cancer
Background Carnitine is related to malaise, and cisplatin is associated with decreased carnitine. The purpose of this study was to elucidate the effects of one course of induction chemotherapy (IC) for head and neck cancer on blood carnitine levels,